Ποια είναι η τιμή για Mankind Pharma Limited (MANKIND)

Η τιμή για Mankind Pharma Limited (MANKIND) είναι $26.10

Ποια είναι η κεφαλαιοποίηση αγοράς για Mankind Pharma Limited (MANKIND)

Η κεφαλαιοποίηση αγοράς για Mankind Pharma Limited (MANKIND) είναι $10.78B

Mankind Pharma Limited (MANKIND) Τιμή και Κεφαλαιοποίηση Αγοράς

Mankind Pharma Limited specializes in the development, manufacturing, and marketing of a broad range of pharmaceutical medications and consumer health goods. Operating predominantly in India, the company also caters to international markets. Its pharmaceutical division focuses on both acute and chronic therapeutic areas, encompassing a wide spectrum of medical conditions such as infectious diseases, cardiovascular ailments, gastrointestinal disorders, diabetes, dermatology, pain management, neuro/CNS issues, nutritional support (vitamins/minerals), and respiratory problems. Complementing its pharmaceutical portfolio, the consumer healthcare segment offers diverse products, including condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. Key brands under its umbrella include Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar. Furthermore, the company's business activities are diversified, extending to the trading and export of pharmaceutical and healthcare products, as well as the manufacturing of various goods such as packaging materials, ayurvedic products, bulk drugs, and general consumer items. Mankind Pharma also holds interests in real estate, leasing, hospitality, and IT services. Established in 1986, Mankind Pharma Limited maintains its headquarters in New Delhi, India.

Η τιμή για MANKIND	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$12,235.24 $10.78B	NVDA	$5.053T	+46,778.60%
$11,051.90 $10.78B	AAPL	$4.564T	+42,244.68%
$10,158.70 $10.78B	GOOG	$4.196T	+38,822.45%
$8,787.23 $10.78B	MSFT	$3.629T	+33,567.73%
$6,831.22 $10.78B	AMZN	$2.821T	+26,073.40%

Η τιμή για MANKIND

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$12,235.24 $10.78B